Take once a Week June 09: Aduhelm Approval and ASCO Discussions Take Once a Week (QW)

In this episode of Take Once a Week, we will discuss the approval of Biogen's Aduhelm as well as some of the major discussions that occurred this past week at ASCO. If you like this episode and others like it, be sure to subscribe!



LINKS TO ALL STORIES:


https://www.biopharmadive.com/news/biogen-aduhelm-confirmatory-study-fda-approval/601422/

https://www.biopharmadive.com/news/a-first-of-its-kind-alzheimers-drug-raises-heavy-questions-around-who-will/601434/

https://www.biopharmadive.com/news/asco-2021-takeaways-adjuvant-immunotherapy-fate-cullinan/601384/

https://www.fiercepharma.com/pharma/1-2b-deal-for-molnupiravir-u-s-bets-merck-to-finally-provide-effective-covid-19-treatment


#pharmacy #news #pharma #pharmaupdates #podcast #academic #vaccine #alzheimers #developments


---

Send in a voice message: https://podcasters.spotify.com/pod/show/take-once-a-week/message